Back to Results
First PageMeta Content
Pharmaceuticals policy / Pharmaceutical industry / Counterfeit consumer goods / Food and Drug Administration / Office of Criminal Investigations / Counterfeit medications / Epedigree / Generic drug / Prescription medication / Pharmaceutical sciences / Pharmacology / Health


CaseStudy-UnsafeDrugs_v4.indd
Add to Reading List

Document Date: 2014-03-12 13:47:01


Open Document

File Size: 533,45 KB

Share Result on Facebook

City

New York / /

Company

Biochimica Opos / Baxter International / RX Healthcare Inc. / Roussel / Parexel Consulting / Ranbaxy Laboratories Ltd. / Novo Nordisk / Aventis Pharma AG / Ranbaxy Inc. / Altec Medical Inc / Ranbaxy Labs / New England Journal / iStockphoto / Flavine International Inc. / Henkel / Bloomberg / /

Continent

Europe / /

Country

France / Panama / China / India / Romania / Italy / Turkey / United States / /

Currency

USD / /

Event

M&A / Person Communication and Meetings / Product Issues / Product Recall / /

Facility

Health-System Pharmacy / /

IndustryTerm

illegitimate products / drug product / owned subsidiary / undisclosed manufacturing sites / stronger product / foreign manufacturer / pharmaceutical broker / pharmaceutical wholesalers / drug broker / supply chain / manufacturing standards / supply chain management / pharmaceutical supply system / pharmaceutical manufacturer / active and bulk chemical ingredients / active pharmaceutical ingredients / pharmaceutical supply chain / drug manufacturing / pharmaceutical products / unapproved manufacturing plants / chemical structure / /

MedicalCondition

counterfeit injectable anemia / Medication-Associated Diethylene Glycol Mass Poisoning / Counterfeit cancer / diabetes / epilepsy / Acute Renal Failure / Another counterfeit cancer / Cough / anemia / /

MedicalTreatment

dialysis / antibiotics / /

Organization

U.S. House Committee on Criminal Justice / Drug Policy / and Human Resources / Southern Division / World Health Organization / U.S. government / Panamanian government / office of Criminal Investigation / office of Criminal Investigations / Food and Drug Administration / U.S. Government Accountability Office / Federal Bureau of Investigation / Department of Justice / Subcommittee on Oversight and Investigations / U.S. District Court for the District of Maryland / Congress / U.S. Attorney’s Office / U.S. House Energy and Commerce Committee / U.S. Centers for Disease Control and Prevention / /

Person

Michelle M. Ciolek / Pharmacy / Kevin Fagan / Katherine Eban / Malvinder Singh / Steve Usdin / Justin Blum / Robert L. Parkinson / Cheryl A. Thompson / Baxter Healthcare / James M. Butler / Carol Lewis / Donna Young / E. Danielle Rentz / John Henkel / /

Position

drug broker / CEO / CEO and managing director / wholesaler / U.S. attorney / Manhattan U.S. Attorney / special agent / pharmaceutical broker / /

Product

gentamicin / Avastin / penicillin / Levemir / cefaclor / Activation / Heparin Associated With Adverse Clinical Events / /

ProvinceOrState

Georgia / Texas / Kentucky / Maryland / Tennessee / Florida / North Carolina / /

PublishedMedium

Morbidity and Mortality Weekly Report / New England Journal of Medicine / /

Region

southern New York / /

Technology

html / dialysis / pdf / http / /

URL

www.fda.gov/fdac/departs/1998/198_irs.html / http /

SocialTag